Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action

Sexually transmitted diseases (STDs) are produced by pathogens like bacteria, fungi, parasites, and viruses, and may generate severe health problems such as cancer, ulcers, and even problems in the newborn. This narrative review aims to present updated information about the use of natural bioactive compounds for the prevention and treatment of sexually transmitted infections. A search of the literature was performed using databases and search engines such as PubMed, Scopus, Google Scholar and Science Direct. From the pharmacotherapeutic management point of view, any strategies for prevention should contain medical approaches. The bioactive compounds obtained from natural products have shown biological effects against different microorganisms for the treatment of these diseases. The main results showed antimicrobial, antiprotozoal, antifungal and antiviral effects such as HIV. Also, the molecular mechanisms, signalling pathways and action targets of natural compounds were highlighted, thus justifying bacterial and antifungal inhibition, apoptosis or reduction of viral replication. From the data of our study, we can conclude that natural compounds may be a significant source for adjuvant drugs / complementary therapies in the treatment of STDs. With all these benefits, the future must conduct extensive clinical trials and the development of pharmaceutical nanotechnologies for a greater therapeutic effect.

[1]  B. Salehi,et al.  Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits , 2021, Frontiers in Pharmacology.

[2]  B. Salehi,et al.  Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence , 2021, Frontiers in Pharmacology.

[3]  D. Calina,et al.  The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol , 2021, Frontiers in Pharmacology.

[4]  D. Calina,et al.  Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety , 2020, Toxicology Reports.

[5]  B. Salehi,et al.  Ficus plants: State of the art from a phytochemical, pharmacological, and toxicological perspective , 2020, Phytotherapy research : PTR.

[6]  B. Salehi,et al.  Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development , 2020, Immunologic Research.

[7]  M. Friedman,et al.  Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review , 2020, BMC Complementary Medicine and Therapies.

[8]  D. Calina,et al.  COVID-19 vaccines: ethical framework concerning human challenge studies , 2020, DARU Journal of Pharmaceutical Sciences.

[9]  Aristidis Tsatsakis,et al.  Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review) , 2020, International journal of molecular medicine.

[10]  M. Sharifi-Rad,et al.  Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds , 2020, International journal of environmental research and public health.

[11]  J. Pezzuto,et al.  Best practice in research - Overcoming common challenges in phytopharmacological research , 2020 .

[12]  B. Salehi,et al.  Avocado–Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited , 2020, Biomolecules.

[13]  C. Chan,et al.  Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives , 2019, Journal of oncology.

[14]  Sen,et al.  Cucurbita Plants: From Farm to Industry , 2019, Applied Sciences.

[15]  B. Salehi,et al.  Veronica Plants—Drifting from Farm to Traditional Healing, Food Application, and Phytopharmacology , 2019, Molecules.

[16]  C. Navarrete-Dechent,et al.  Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment , 2019, Clinical, cosmetic and investigational dermatology.

[17]  T. Tasca,et al.  Nectandra as a renewable source for (+)-α-bisabolol, an antibiofilm and anti-Trichomonas vaginalis compound. , 2019, Fitoterapia.

[18]  Chasity E Trammell,et al.  Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor , 2019, mBio.

[19]  Z. Selamoğlu,et al.  Cucurbits Plants: A Key Emphasis to Its Pharmacological Potential , 2019, Molecules.

[20]  A. Moteetee,et al.  Medicinal plants used for the treatment of sexually transmitted infections in the Maseru District, Lesotho: Antimicrobial validation, phytochemical and cytotoxicity studies , 2019, South African Journal of Botany.

[21]  B. Salehi,et al.  Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, Aloe vera, Green Tea and Coffee Properties , 2019, Biomolecules.

[22]  M. E. Alvarez-Sánchez,et al.  Trichomonicidal activity of a new anthraquinone isolated from the roots of Morinda panamensis Seem , 2019, Drug development research.

[23]  M. Fakhar,et al.  Medicinal Plants with Anti-Trichomonas vaginalis Activity in Iran: A Systematic Review , 2019, Iranian journal of parasitology.

[24]  D. Calina,et al.  Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections , 2018, Experimental and therapeutic medicine.

[25]  Faik Gökalp The inhibition effect of garlic‐derived compounds on human immunodeficiency virus type 1 and saquinavir , 2018, Journal of biochemical and molecular toxicology.

[26]  M. Friedman,et al.  Potato Peels and Their Bioactive Glycoalkaloids and Phenolic Compounds Inhibit the Growth of Pathogenic Trichomonads. , 2018, Journal of agricultural and food chemistry.

[27]  D. Calina,et al.  Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review) , 2018, International journal of oncology.

[28]  Mahdi Delavari,et al.  Induction of Apoptosis by Alcoholic Extract of Combination Verbascum thapsus and Ginger officinale on Iranian Isolate of Trichomonas vaginalis , 2018, Iranian journal of parasitology.

[29]  D. Calina,et al.  Staphylococcus aureus colonisation in patients from a primary regional hospital , 2017, Molecular medicine reports.

[30]  J. Staden,et al.  Pharmacological properties of extracts from six South African medicinal plants used to treat sexually transmitted infections (STIs) and related infections , 2017 .

[31]  B. Foxman,et al.  Recurrent vulvovaginal candidiasis. , 2017, Annals of epidemiology.

[32]  Charlotte A Gaydos,et al.  Mycoplasma genitalium , 2017, The Journal of infectious diseases.

[33]  M. Plummer,et al.  Worldwide burden of cancer attributable to HPV by site, country and HPV type , 2017, International journal of cancer.

[34]  Daniel H. Foil,et al.  Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis). , 2017, Phytochemistry letters.

[35]  H. Vazini Anti-Trichomonas vaginalis activity of nano Micana cordifolia and Metronidazole: an in vitro study , 2017, Journal of Parasitic Diseases.

[36]  A. Leung,et al.  Molluscum Contagiosum: An Update. , 2017, Recent patents on inflammation & allergy drug discovery.

[37]  N. Lopes,et al.  The Caatinga endemic Manilkara rufula possesses remarkable activity against Trichomonas vaginalis and Tritrichomonas foetus. , 2017, Experimental parasitology.

[38]  D. Calina,et al.  Antimicrobial resistance development following surgical site infections , 2016, Molecular medicine reports.

[39]  M. Moyo,et al.  Antimicrobial, antioxidant and cytotoxicity of isolated compounds from leaves of Pappea capensis , 2017 .

[40]  P. Mamba,et al.  Anti-microbial, anti-Inflammatory and HIV-1 reverse transcriptase activity of selected South African plants used to treat sexually transmitted diseases , 2016 .

[41]  M. Cusini,et al.  2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology.

[42]  G. Mena-Rejón,et al.  ANTIPROTOZOAL ACTIVITY OF EXTRACTS OF ELAEODENDRON TRICHOTOMUM (CELASTRACEAE) , 2016, African journal of traditional, complementary, and alternative medicines : AJTCAM.

[43]  D. Lowy,et al.  Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. , 2016, Journal of the National Cancer Institute.

[44]  A. Docea,et al.  ETIOLOGICAL DIAGNOSIS AND PHARMACOTHERAPEUTIC MANAGEMENT OF PARAPNEUMONIC PLEURISY , 2016 .

[45]  S. Lautenschlager,et al.  European guideline for the management of chancroid , 2016 .

[46]  J. Sobel Recurrent vulvovaginal candidiasis. , 1987, American journal of obstetrics and gynecology.

[47]  Marleen Temmerman,et al.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.

[48]  S. Kulkarni,et al.  Antimicrobial activity of plant extracts against sexually transmitted pathogens , 2015, Natural product research.

[49]  N. Cho,et al.  Natural Products for the Treatment of Trachoma and Chlamydia trachomatis , 2015, Molecules.

[50]  Peter Vickerman,et al.  Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012 , 2015, PloS one.

[51]  K. Workowski,et al.  Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  H. Chesson,et al.  The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States , 2014, Sexually transmitted diseases.

[53]  H. Yousefi,et al.  Chemical composition of essential oil and anti trichomonas activity of leaf, stem, and flower of Rheum ribes L. extracts , 2014, Avicenna journal of phytomedicine.

[54]  N. Low,et al.  Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. , 2014, Vaccine.

[55]  A. Badawy,et al.  In vitro anti-Trichomonas vaginalis activity of Pistacia lentiscus mastic and Ocimum basilicum essential oil , 2015, Journal of Parasitic Diseases.

[56]  D. Naidoo,et al.  Plants traditionally used individually and in combination to treat sexually transmitted infections in northern Maputaland, South Africa: antimicrobial activity and cytotoxicity. , 2013, Journal of ethnopharmacology.

[57]  T. Tasca,et al.  Remarkable Anti-Trichomonas vaginalis Activity of Plants Traditionally Used by the Mbyá-Guarani Indigenous Group in Brazil , 2013, BioMed research international.

[58]  R. Vargas,et al.  Anti-Trichomonas vaginalis activity of Hypericum polyanthemum extract obtained by supercritical fluid extraction and isolated compounds. , 2013, Parasitology international.

[59]  S. Cunningham,et al.  Pubic hair removal: a risk factor for ‘minor’ STI such as molluscum contagiosum? , 2013, Sexually Transmitted Infections.

[60]  S. Garland,et al.  A review of clinical trials of human papillomavirus prophylactic vaccines. , 2012, Vaccine.

[61]  L. Manhart,et al.  Mycoplasma genitalium, an emerging sexually transmitted pathogen. , 2012, Medecine et maladies infectieuses.

[62]  P. Klasse The molecular basis of HIV entry , 2012, Cellular microbiology.

[63]  R. Hay,et al.  Scabies in the developing world--its prevalence, complications, and management. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[64]  R. B. Giordani,et al.  First report of anti-Trichomonas vaginalis activity of the medicinal plant Polygala decumbens from the Brazilian semi-arid region, Caatinga , 2011, Parasitology Research.

[65]  K. Workowski,et al.  Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  E. Ho,et al.  Syphilis: using modern approaches to understand an old disease. , 2011, The Journal of clinical investigation.

[67]  John P. Moore,et al.  Inhibition of HIV-1 and M-MLV reverse transcriptases by a major polyphenol (3,4,5 tri-O-galloylquinic acid) present in the leaves of the South African resurrection plant, Myrothamnus flabellifolia , 2011, Journal of enzyme inhibition and medicinal chemistry.

[68]  A. Giuliano,et al.  Analysis of overdispersed count data: application to the Human Papillomavirus Infection in Men (HIM) Study , 2011, Epidemiology and Infection.

[69]  L. Lindholm,et al.  On the evolution of the sexually transmitted bacteria Haemophilus ducreyi and Klebsiella granulomatis , 2011, Annals of the New York Academy of Sciences.

[70]  D. Taylor-Robinson,et al.  Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly , 2011, Clinical Microbiology Reviews.

[71]  G. El-Sherbiny,et al.  The Effect of Commiphora molmol (Myrrh) in Treatment of Trichomoniasis vaginalis infection , 2011, Iranian Red Crescent medical journal.

[72]  J. van Staden,et al.  Antimicrobial properties and phenolic contents of medicinal plants used by the Venda people for conditions related to venereal diseases. , 2011, Journal of ethnopharmacology.

[73]  S. Lautenschlager,et al.  European guideline for the management of chancroid, 2011 , 2011, International journal of STD & AIDS.

[74]  E. Stratman,et al.  Diagnosis of Atypical Molluscum Contagiosum: The Utility of a Squash Preparation , 2011, Clinical Medicine & Research.

[75]  W. Geisler Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  N. Schmidt,et al.  A Randomized Treatment Trial: Single Versus 7-Day Dose of Metronidazole for The Treatment of Trichomonas Vaginalis Among HIV-Infected Women , 2010, Journal of acquired immune deficiency syndromes.

[77]  M. Forcier,et al.  An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention , 2010, Dermatologic therapy.

[78]  S. V. van Vuuren,et al.  An antimicrobial investigation of plants used traditionally in southern Africa to treat sexually transmitted infections. , 2010, Journal of ethnopharmacology.

[79]  N. Silverberg,et al.  Vertically Transmitted Molluscum Contagiosum Infection , 2010, Pediatrics.

[80]  S. Wen,et al.  Baicalin suppresses expression of Chlamydia protease-like activity factor in Hep-2 cells infected by Chlamydia trachomatis. , 2009, Fitoterapia.

[81]  V. De Maertelaer,et al.  Curettage treatment for molluscum contagiosum: a follow‐up survey study , 2008, The British journal of dermatology.

[82]  M. Singh,et al.  Anti-Trichomonas activity of Sapindus saponins, a candidate for development as microbicidal contraceptive. , 2008, The Journal of antimicrobial chemotherapy.

[83]  F. Tangy,et al.  In vitro activity of dermaseptin S4 derivatives against genital infections pathogens. , 2008, Regulatory toxicology and pharmacology : RTP.

[84]  O. Aiyelaagbe,et al.  The Antimicrobial Activity of Jatropha multifida Extracts and Chromatographic Fractions Against Sexually Transmitted Infections , 2008 .

[85]  D. Mabey,et al.  Global epidemiology and control of Trichomonas vaginalis , 2008, Current opinion in infectious diseases.

[86]  W. Weger,et al.  Treatment of molluscum contagiosum with a pulsed dye laser: Pilot study with 19 children , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[87]  A. Wald,et al.  Genital herpes , 2008, The Lancet.

[88]  L. Kambizi Extracts from Aloe ferox and Withania somnifera inhibit Candida albicans and Neisseria gonorrhoea , 2008 .

[89]  H. Lawson,et al.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[90]  M. Stanley,et al.  Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer , 2007, British Journal of Cancer.

[91]  K. Workowski,et al.  Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[92]  J. Richens Donovanosis (granuloma inguinale) , 2006, Sexually Transmitted Infections.

[93]  R. Wolf,et al.  Itch and scratch: scabies and pediculosis. , 2006, Clinics in dermatology.

[94]  O. Chosidow Clinical practices. Scabies. , 2006, The New England journal of medicine.

[95]  J. van Staden,et al.  Antibacterial and antifungal activity of traditional medicinal plants used against venereal diseases in South Africa. , 2006, Journal of ethnopharmacology.

[96]  C. Butler,et al.  Interventions for cutaneous molluscum contagiosum. , 2006, The Cochrane database of systematic reviews.

[97]  Global strategy for the prevention and control of sexually transmitted infections : 2006 – 2015 Key messages , 2006 .

[98]  B. Kotowicz,et al.  Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. , 2006, Advances in medical sciences.

[99]  J. Jensen,et al.  Mycoplasma genitalium: prevalence, clinical significance, and transmission , 2005, Sexually Transmitted Infections.

[100]  E. Hook,et al.  Chlamydial and Gonococcal Infection in Men Without Polymorphonuclear Leukocytes on Gram Stain: Implications for Diagnostic Approach and Management , 2005, Sexually transmitted diseases.

[101]  J. Jensen,et al.  Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection , 2005, Sexually Transmitted Infections.

[102]  V. Tandon,et al.  Preliminary Studies on Activity of Ocimum sanctum, Drynaria quercifolia, and Annona squamosa Against Neisseria gonorrhoeae , 2005, Sexually transmitted diseases.

[103]  Trends in HIV/AIDS diagnoses--33 states, 2001-2004. , 2005, MMWR. Morbidity and mortality weekly report.

[104]  B. Goh,et al.  Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis , 2004, Sexually Transmitted Infections.

[105]  M. C. Basualdo,et al.  HIV-1 inhibitory compounds from Calophyllum brasiliense leaves. , 2004, Biological & pharmaceutical bulletin.

[106]  J. Peipert,et al.  Screening for Syphilis Infection: Recommendation Statement , 2004, The Annals of Family Medicine.

[107]  M. C. Basualdo,et al.  HIV-1 inhibition by extracts of Clusiaceae species from Mexico. , 2004, Biological & pharmaceutical bulletin.

[108]  B. Vuylsteke,et al.  Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens , 2003, Sexually transmitted infections.

[109]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[110]  Y. Hara,et al.  In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneumoniae. , 2003, Japanese journal of infectious diseases.

[111]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[112]  D. Lewis Chancroid: clinical manifestations, diagnosis, and management , 2003, Sexually transmitted infections.

[113]  M. M. Amorim,et al.  Tratamento da vaginose bacteriana com gel vaginal de Aroeira (Schinus terebinthifolius Raddi): ensaio clínico randomizado , 2003 .

[114]  M. Pontari Inflammation and anti-inflammatory therapy in chronic prostatitis , 2002 .

[115]  N. O’Farrell Donovanosis , 2002, Sexually transmitted infections.

[116]  E. Erbelding,et al.  Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[117]  W. Levine,et al.  SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES 2002 , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[118]  Michel A Pontari Inflammation and anti-inflammatory therapy in chronic prostatitis. , 2002, Urology.

[119]  D. Mabey Epidemiology of STIs: worldwide , 2001 .

[120]  R. Gilman,et al.  18S Ribosomal DNA-Based PCR for Diagnosis ofTrichomonas vaginalis , 2000, Journal of Clinical Microbiology.

[121]  C. Burkhart,et al.  An epidemiologic and therapeutic reassessment of scabies. , 2000, Cutis.

[122]  K. Lee,et al.  Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release. , 2000, Phytochemistry.

[123]  O. Chosidow Scabies and pediculosis , 2000, The Lancet.

[124]  G. P. Talwar,et al.  Polyherbal Formulations with Wide Spectrum Antimicrobial Activity Against Reproductive Tract Infections and Sexually Transmitted Pathogens , 2000, American journal of reproductive immunology.

[125]  W. Leong,et al.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. , 1999, The New England journal of medicine.

[126]  B. Foxman,et al.  Risk Factors for Vulvovaginal Candidiasis: A Case- Control Study among University Students , 1996, Epidemiology.

[127]  J. Sobel,et al.  Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. , 1995, American journal of obstetrics and gynecology.

[128]  G. Ridgway,et al.  Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. , 1993, The Journal of antimicrobial chemotherapy.

[129]  L. Corey,et al.  Risk Factors for the Sexual Transmission of Genital Herpes , 1992, Annals of Internal Medicine.

[130]  John Richens The diagnosis and treatment of donovanosis (granuloma inguinale). , 1991, Genitourinary medicine.

[131]  P. Furr,et al.  Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium. , 1991, FEMS microbiology letters.

[132]  C. Lee,et al.  Natural history of HIV and AIDS. , 1990, AIDS care.

[133]  A. P. Kiriushchenkov [Genital candidiasis]. , 1990, Fel'dsher i akusherka.

[134]  O. Arya Donovanosis , 1988 .

[135]  K. Holmes,et al.  Genital herpes simplex virus infections: clinical manifestations, course, and complications. , 1983, Annals of internal medicine.

[136]  W H Foege,et al.  Centers for Disease Control , 1981, Journal of public health policy.

[137]  L. G. Koss,et al.  Cervical Cancer , 1981, Current Topics in Pathology.

[138]  J. O. Alexander Scabies and pediculosis. , 1968, The Practitioner.